Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 474121 in Healthy Male Subjects (an Open-label, Two-period Fixed Sequence Design Study)
Latest Information Update: 14 Mar 2024
At a glance
- Drugs BI 474121 (Primary) ; Itraconazole
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 06 Apr 2021 Status changed from active, no longer recruiting to completed.
- 02 Mar 2021 Status changed from recruiting to active, no longer recruiting.
- 22 Feb 2021 Allocation changed to Non-Randomized.